Why Psychedelics Might Be the Breakthrough That PTSD Patients Need | Kevin Ryan | The Generalist

In The Generalist podcast, Mario Gabriele interviews Kevin Ryan, a successful serial entrepreneur and founder of AlleyCorp, about his career, investment strategies, and views on emerging trends. They discuss Ryan's early experiences with Dilbert and DoubleClick, AlleyCorp's approach to incubation, and the factors behind MongoDB's success. Ryan shares insights on the changing landscape of e-commerce, the importance of AI across industries, and his ventures into psychedelics for mental health and AI-powered material science. He also touches on public policy experiments, cultural differences in entrepreneurship between the U.S. and Europe, and his reading habits.

Outlines

Part 1: Entrepreneurship and AlleyCorp Genesis

Part 2: Future Focus and AI

Part 3: Psychedelics and Transcend

Part 4: Material Science and Tech Ecosystems

Part 5: Recommendations and Reflections

Sign in to continue reading, translating and more.

Continue

Why Psychedelics Might Be the Breakthrough That PTSD Patients Need | Kevin Ryan

The Generalist

Part 1: Entrepreneurship and AlleyCorp Genesis

Introduction to Entrepreneurship, Team Building, and the Genesis of AlleyCorp

From DoubleClick to AlleyCorp: A Journey Through Tech Ventures

Systematizing Incubation and the MongoDB Success Story

The Gilt Groupe Experience: E-commerce Dynamics and Business Model Evolution

Part 2: Future Focus and AI

AlleyCorp's Future Focus, Time Management, and Board Dynamics

The Importance of Founding Companies and Future Themes: AI and Retraining

Part 3: Psychedelics and Transcend

The Psychedelics Opportunity: Michael Pollan's Influence and Yale's Research

Psychedelics: Applications, Limitations, and Neuroplasticity

Administration of Psychedelics and Transcend's Role in Psychedelic Research

Transcend's Clinical Trials, FDA Breakthrough Designation, and the High Cost of Biotech

Government Initiatives, Market Size, and Future of Psychedelic Treatment

Part 4: Material Science and Tech Ecosystems

Introduction to Material Science and its Impact on Everyday Life

AI's Role in Material Science and the Radical Company

Comparing Tech Ecosystems: US vs. Europe

Cultural Differences and Long-Term Investments

Public Policy Experiments and Psychedelics in Native American Culture

Part 5: Recommendations and Reflections

Book Recommendations and Reflections on New York City's Transformation

Why Psychedelics Might Be the Breakthrough That PTSD Patients Need | Kevin Ryan

The Generalist

Part 1: Entrepreneurship and AlleyCorp Genesis

00:00Introduction to Entrepreneurship, Team Building, and the Genesis of AlleyCorp

Introduction to Entrepreneurship, Team Building, and the Genesis of AlleyCorp

07:11From DoubleClick to AlleyCorp: A Journey Through Tech Ventures

From DoubleClick to AlleyCorp: A Journey Through Tech Ventures

10:01Systematizing Incubation and the MongoDB Success Story

Systematizing Incubation and the MongoDB Success Story

13:42The Gilt Groupe Experience: E-commerce Dynamics and Business Model Evolution

The Gilt Groupe Experience: E-commerce Dynamics and Business Model Evolution

Part 2: Future Focus and AI

17:40AlleyCorp's Future Focus, Time Management, and Board Dynamics

AlleyCorp's Future Focus, Time Management, and Board Dynamics

22:25The Importance of Founding Companies and Future Themes: AI and Retraining

The Importance of Founding Companies and Future Themes: AI and Retraining

Part 3: Psychedelics and Transcend

25:50The Psychedelics Opportunity: Michael Pollan's Influence and Yale's Research

The Psychedelics Opportunity: Michael Pollan's Influence and Yale's Research

29:25Psychedelics: Applications, Limitations, and Neuroplasticity

Psychedelics: Applications, Limitations, and Neuroplasticity

32:05Administration of Psychedelics and Transcend's Role in Psychedelic Research

Administration of Psychedelics and Transcend's Role in Psychedelic Research

35:53Transcend's Clinical Trials, FDA Breakthrough Designation, and the High Cost of Biotech

Transcend's Clinical Trials, FDA Breakthrough Designation, and the High Cost of Biotech

40:09Government Initiatives, Market Size, and Future of Psychedelic Treatment

Government Initiatives, Market Size, and Future of Psychedelic Treatment

Part 4: Material Science and Tech Ecosystems

44:29Introduction to Material Science and its Impact on Everyday Life

Introduction to Material Science and its Impact on Everyday Life

47:27AI's Role in Material Science and the Radical Company

AI's Role in Material Science and the Radical Company

52:05Comparing Tech Ecosystems: US vs. Europe

Comparing Tech Ecosystems: US vs. Europe

57:52Cultural Differences and Long-Term Investments

Cultural Differences and Long-Term Investments

1:01:24Public Policy Experiments and Psychedelics in Native American Culture

Public Policy Experiments and Psychedelics in Native American Culture

Part 5: Recommendations and Reflections

1:04:15Book Recommendations and Reflections on New York City's Transformation

Book Recommendations and Reflections on New York City's Transformation